8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 25, 2014 (November 21, 2014)

NANOPHASE TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   0-22333   36-3687863
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer Identification No.)

 

1319 Marquette Drive, Romeoville, Illinois   60446
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (630) 771-6700

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.02 Departure of Certain Officers

On November 21, 2014, Dr. Pat Murray, the Vice President of Research and Development at Nanophase Technologies Corporation (the “Company”) resigned from his position effective December 5, 2014. Following Dr. Murray’s departure, and until his successor is hired, the Company’s President and CEO, Mr. Jess Jankowski, will assume responsibility for the functions Dr. Murray currently performs, supported by the Company’s senior technical team.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      

NANOPHASE TECHNOLOGIES CORPORATION

       (Registrant)

November 25, 2014

       

/s/    FRANK CESARIO       

(Date)

       

FRANK CESARIO

Chief Financial Officer